Effect of Tyrosin Kinase Inhibitors on NK Cell and ILC3 Development and Function

Tyrosin kinase inhibitors (TKI) sharply improved the prognosis of Chronic Myeloid Leukemia (CML) and of Philadelphia(+) Acute Lymphoblastic Leukemia (Ph(+)ALL) patients. However, TKI are not curative because of the development of resistance and lack of complete molecular remission in the majority of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Immunol
Egile Nagusiak: Damele, Laura, Montaldo, Elisa, Moretta, Lorenzo, Vitale, Chiara, Mingari, Maria Cristina
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2018
Gaiak:
Immunology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6207002/
https://ncbi.nlm.nih.gov/pubmed/30405627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02433
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak